The significance of NAD + metabolites and nicotinamide N-methyltransferase in chronic kidney disease

MLA

Rina Takahashi, et al. “The Significance of NAD + Metabolites and Nicotinamide N-Methyltransferase in Chronic Kidney Disease.” Scientific Reports, vol. 12, no. 1, Nov. 2021. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....6f827be50e33c722ab83e1bdaad84927&authtype=sso&custid=ns315887.

APA

Rina Takahashi, Takeshi Kanda, Motoaki Komatsu, Tomoaki Itoh, Hitoshi Minakuchi, Hidenori Urai, Tomohiro Kuroita, Shuhei Shigaki, Tasuku Tsukamoto, Naoko Higuchi, Minoru Ikeda, Risa Yamanaka, Norito Yoshimura, Takashi Ono, Hideo Yukioka, Kazuhiro Hasegawa, Hirobumi Tokuyama, Shu Wakino, & Hiroshi Itoh. (2021). The significance of NAD + metabolites and nicotinamide N-methyltransferase in chronic kidney disease. Scientific Reports, 12(1).

Chicago

Rina Takahashi, Takeshi Kanda, Motoaki Komatsu, Tomoaki Itoh, Hitoshi Minakuchi, Hidenori Urai, Tomohiro Kuroita, et al. 2021. “The Significance of NAD + Metabolites and Nicotinamide N-Methyltransferase in Chronic Kidney Disease.” Scientific Reports 12 (1). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....6f827be50e33c722ab83e1bdaad84927&authtype=sso&custid=ns315887.